Request for Support in Dissertation Research on Genetic Competencies for Pharmacist working in cancer

Dear Members,

The BOPA research committee would like to invite members to participate in a research project on Genetic core competencies for clinical pharmacists in the cancer setting: a literature review and Delphi method. Below is the letter of invitation:

“My name is Delia D’Agostino, and I am a Senior Rotational Pharmacist at The Royal Marsden NHS Foundation Trust, London. I am currently undertaking a master’s degree in clinical oncology and would greatly appreciate your support in my dissertation research.

This study aims to define a core curriculum of genetic competencies essential for clinical pharmacists working in oncology. Additionally, it seeks to explore practical approaches for delivering genetic education to the pharmacy workforce.

The project consists of a literature review to identify relevant genetic competencies, followed by the development of a Delphi methodology-based questionnaire. I seek the support of BOPA members in completing this questionnaire to achieve a consensus on the competencies and their optimal educational delivery.

The process will proceed as follows:
1. If interested in participating in the questionnaire, BOPA members receiving this email are asked to come forward by replying by 16/05/25. Note that the inclusion criteria are Band 7 pharmacists and above with at least two years of cancer experience.
2. The first questionnaire will be distributed on 30/05/2025 to those who had expressed interest via a dedicated online platform, with a link included in the invitation email.
3. The questionnaire will undergo two further rounds in June and July 2025 respectively, incorporating responses from previous rounds. Participants will provide consent for the anonymous use of their answers. Ethical approval is not required as no confidential data will be collected. The timeline for each round will be the following:

  • Round 1 completion by 13/06/2025
  • Round 2 completion by 27/06/2025
  • Round 3 completion by 11/07/2025

Each round of the questionnaire will take around 1 hour to complete

4. Data analysis and results presentation will follow and be completed by October 2025.
Please find attached the project protocol for further details.

If you fit the inclusion criteria as above (point 1), and you are interested in participating in the project, I kindly request your response by 16/05/25. To do so, please send an expression of interest to [email protected] stating your email address. Please note that this is the same address you will be contacted on upon starting of each questionnaire round and where you will receive any other relevant information about the project.

Should you have any questions, please do not hesitate to contact me.”

Kind regards,

BOPA research committee

on behalf of Delia D’Agostino.

 

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article